Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01516632 · ClinicalTrials.gov registry record · NA

Smoking Cessation Via Text Messaging: Feasibility Testing of Stop My Smoking USA

A NA study of Smoking Cessation, sponsored by Center for Innovative Public Health Research.

Completed
Registry status
NA
Development phase
164
Enrollment target
1
Study location

NCT01516632 is a NA study of Smoking Cessation that has completed, run by Center for Innovative Public Health Research. The registered enrollment target is 164 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01516632, a NA study of Smoking Cessation, has completed, sponsored by Center for Innovative Public Health Research.

COMPLETED
Registry status
NA
Development phase
164 participants
Enrollment target
1
Study location

Study Summary

The investigators developed a text messaging-based smoking cessation program called SMS (Stop My Smoking) USA. It was tailored for the unique needs and smoking habits of young adults. The investigators hypothesized that those in the SMS USA intervention would be significantly more likely to be quit at 6-months compared to the attention-matched control group.

Conditions Studied

Interventions

  • BEHAVIORAL SMS USA

Study Locations (1)

California

  • Internet Solutions for Kids, Inc. - Santa Ana

Trial Details

FieldValue
Enrollment Target 164 participants
Start Date 2009-06
Est. Completion 2011-12
Phase NA

What the Registry Record Tells You About NCT01516632

The ClinicalTrials.gov registry entry for NCT01516632 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (65% lower). The listed sponsor is Center for Innovative Public Health Research, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which SMS USA is the first listed.

NCT01516632 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01516632 about?

NCT01516632 is a clinical study titled "Smoking Cessation Via Text Messaging: Feasibility Testing of Stop My Smoking USA". The investigators developed a text messaging-based smoking cessation program called SMS (Stop My Smoking) USA. It was tailored for the unique needs and smoking habits of young adults. The investigators hypothesized that those in the SMS USA intervention would be significantly more likely to be quit ...

What is the current status of trial NCT01516632?

This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2009-06. Estimated completion is 2011-12.

What conditions does trial NCT01516632 study?

This clinical trial studies the following conditions: Smoking Cessation.

What interventions are being tested in trial NCT01516632?

The interventions under investigation include: SMS USA (BEHAVIORAL).

Who is sponsoring clinical trial NCT01516632?

This trial is sponsored by Center for Innovative Public Health Research, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01516632 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking Cessation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.